top of page

Rewriting The Rules Of Aging

The Next Frontier of Generative AI x Cellular Reprogramming

Programmable, Multi-Factor Human De-Aging At Organism Scale

Frontier AI Modeling Meets De-Aging Science

First-of-its-kind, multi-layer causal in vivo data at unprecedented scale brings frontier generative AI models and agentic systems into systemic human biology - ushering in the era of programmable, multi-factor human de-aging.

High-Capacity Delivery Systems to Unlock the Bottleneck

Large scale genome delivery systems engineered at 100x conventional payload limits, enabling durable yet precisely controllable multi-gene rejuvenation programs delivered across the body, including traditionally hard-to-reach tissues. 

Meet Our Founders

image_edited.jpg
  • LinkedIn

George Church, PhD

Co-Founder

Professor of Genetics at Harvard Medical School

George Church, PhD, is a world-renowned geneticist who is recognized as a driving force in programmable biology, regenerative medicine, and aging research. His breakthroughs include the first direct genome sequencing method, major CRISPR advances, and the Personal Genome Project. 

image.png
  • LinkedIn

Diana Luan, MBA

Co-Founder, CEO

kawamata.jpeg
  • LinkedIn

Masaki Kawamata, PhD

Co-Founder

hayano.jpeg
  • LinkedIn

Motoshi Hayano, PhD 

Co-Founder

image.png
  • LinkedIn

Shoko Iwai, PhD 

VP of Bioinformatics

Investors

image.png
  • LinkedIn

Michael Antonov

Co-founder and Chief Software Architect at Oculus (acquired by Facebook).

Co-founder and CEO of Deep Origin and Formic Ventures, with a focus on healthspan and longevity.

image_edited_edited_edited.png
  • LinkedIn

Yasumasa Yamamoto

Venture Capitalist and Unicorn Investor
External Advisor at McKinsey
Adjunct Professor at Kyoto University, specializing in AI and technology.

image_edited.jpg
image.png
fvp-logo_edited.png
image_edited.jpg

We Take Pride in Our Numbers

100x

Safety

7x

Efficiency

3000x

Precision

Possibilities

Featured In

GEN

Ready to
Get In Touch?

bottom of page